Marleen Keyaerts

Automated threshold selection on whole-body 18F-FDG PET/CT for assessing tumor metabolic response

Ine Dirks, Jef Vandemeulebroucke, Marleen Keyaerts, 2020, Medical Imaging: Image Processing.

Dynamic bioluminescence imaging for quantitative tumour burden assessment using IV or IP administration of d-luciferin: effect on intensity, time kinetics and repeatability of photon emission

Marleen Keyaerts, Axel Bossuyt, Tony Lahoutte, 2008, European Journal of Nuclear Medicine and Molecular Imaging.

Bioluminescence imaging: looking beyond the light.

Marleen Keyaerts, Tony Lahoutte, Vicky Caveliers, 2012, Trends in molecular medicine.

Comparison of the Biodistribution and Tumor Targeting of Two 99mTc-Labeled Anti-EGFR Nanobodies in Mice, Using Pinhole SPECT/Micro-CT

Christian Vanhove, Marleen Keyaerts, Tony Lahoutte, 2008, Journal of Nuclear Medicine.

Synthesis, Preclinical Validation, Dosimetry, and Toxicity of 68Ga-NOTA-Anti-HER2 Nanobodies for iPET Imaging of HER2 Receptor Expression in Cancer

Marleen Keyaerts, Nick Devoogdt, Tony Lahoutte, 2013, The Journal of Nuclear Medicine.

Targeted alpha therapy using short-lived alpha-particles and the promise of nanobodies as targeting vehicle

Marleen Keyaerts, Nick Devoogdt, Tony Lahoutte, 2016, Expert opinion on biological therapy.

Non-invasive assessment of murine PD-L1 levels in syngeneic tumor models by nuclear imaging with nanobody tracers

Marleen Keyaerts, Nick Devoogdt, David Escors, 2017, Oncotarget.